[1]任凌,戴皓洁.125Ⅰ粒子在头颈部腺样囊性癌综合治疗中的作用[J].国际放射医学核医学杂志,2011,35(1):13-16.[doi:10.3760/cma.j.issn.1673-4114.2011.01.004]
　REN Ling,DAI Hao-jie.The effect of 125I seed in comprehensive therapy of the head and neck adenoid cystic carcinoma[J].International Journal of Radiation Medicine and Nuclear Medicine,2011,35(1):13-16.[doi:10.3760/cma.j.issn.1673-4114.2011.01.004]
点击复制

125Ⅰ粒子在头颈部腺样囊性癌综合治疗中的作用(/HTML)
分享到：

《国际放射医学核医学杂志》[ISSN:1673-4114/CN:12-1381/R]

卷:
35
期数:
2011年第1期
页码:
13-16
栏目:
临床核医学
出版日期:
1900-01-01

文章信息/Info

Title:
The effect of 125I seed in comprehensive therapy of the head and neck adenoid cystic carcinoma
作者:
任凌;  戴皓洁
首都医科大学附属北京同仁医院核医学科, 北京 100730
Author(s):
REN Ling;  DAI Hao-jie
Deportment of Nuclear Medicine, Beijing Tong Ren Hospital, Capitol Medical University, Beijing 100730, China
关键词:
癌; 腺样囊性; 碘放射性同位素; 近距离放射疗法
Keywords:
Carcinoma; adenoid cystic; Iodine radioisotopes; Brachytherapy
DOI:
10.3760/cma.j.issn.1673-4114.2011.01.004
摘要:
腺样囊性癌(ACC)常发生于头颈部,临床上大多数患者均采用手术结合放疗的综合治疗方法。手术联合放疗可达到较好的局部控制率,尤其是对手术无法切除的晚期恶性肿瘤,而放疗可缓解局部症状、延缓肿瘤发展。125Ⅰ粒子植入治疗是一种有效的近距离放疗方法,可一次性完成插植,具有周围正常组织损伤轻微、靶区定位准确和操作简单的特点。125Ⅰ粒子可在CT、B超、导航等影像设备的引导下植入肿瘤。应用125Ⅰ粒子植入治疗头颈部ACC已经取得了良好的近期疗效,不良反应的发生率较低。术前制定治疗计划、术中或术后进行质量验证,可保证治疗质量可靠,最好地发挥125Ⅰ粒子植人治疗的作用。
Abstract:
Adenoid cystic carcinoma (ACC)often occurs in head and neck, many patients are treated with surgical operation combined radiation treatment method in clinic. Surgery combined radiation therapy can achieve good local control, especially for those late-stage cancer undlgo patients who cannot undergo surgical resection. Radiation therapy can alleviate local symptoms, retards the growth of tumor. 125I seed interstitial brachytheraphy is an effective treatment method which has the characteristics of minimal damage in normal tissue, accurate positioning in target area and simple operation, and it can he one-time completed. 125I seed can be implanted in tumors through the CT, B ultrasonic and image navigation equipment. Application of 125I seed interstitial brachytheraphy treatment in head and neck ACC has achieved good short-term curative effect. Preoperative establishing treatment plan and intraoperative or postoperative quality verification can guarantee the quality of treatment and make125I seed interstitial brachytheraphy work better.

参考文献/References:

[1] 赵锦,许素玲.头颈部腺样囊性癌放射治疗30例分析及文献复习.肿瘤防治杂志,2000, 7(2):154-155.
[2] 赵科,罗洪,吴亚东,等.放射性125I粒子组织间植入近距离治疗唾液腺恶性肿瘤的初步报告.中国实验方剂学杂志, 2010, 16(14):189-191.
[3] 吕淑珍,张杰,赵京华.联合术后放射性粒子125I组织间植入治疗涎腺腺样囊性癌的初步观察.现代口腔医学杂志,2009, 23(5):550-551.
[4] 刘琳,何彦津.泪腺腺样囊性癌的放射治疗.国际眼科杂志2004, 4(5):900-904.
[5] 张杰,张建国,宋铁砾,等.经CT引导头颈部恶性肿瘤125I放射性粒子的植入.华西口腔医学杂志,2008, 26(1):8-14.
[6] 彭诚,邓嘉胤,王东,等.放射性核素125I粒子植入治疗晚期腺样囊性癌[J/CD]. 中华口腔医学研究杂志(电子版)2008, 2(3):270-276.
[7] 袁航,任统伟,胡元合,等.CT导向下125I粒子组织间种植治疗头颈部肿瘤的临床研究.医学研究杂志,2009, 38(10) 111-112.
[8] 李树玲.新编头颈肿瘤学.北京:科学技术文献出版社,2002:455-457.
[9] 唐东润,宋国祥,孙丰源,等.眼眶泪腺腺样囊性癌手术联合放疗的疗效观察.眼科研究,2002, 20(1):69-71.
[10] Prokopakis EP, Snydcrman CH, Hanna EY, et al.Risk factors for local recurrence of adenoid cystic carcinoma:the role of postoperative radiation therapy. Am J Otolaryngol, 1999, 20(5):281-286.
[11] Kim KH, Sung MW, Chung PS,et al. Adenoid cystic carcinoma of the head and neck. Arch Otolaryngol Head Neck Surg, 1994, 120(7):721-726.
[12] 王俊杰,修典荣,冉维强.放射性粒子组织间近距离治疗肿瘤. 2版.北京:北京大学医学出版社,2004:18-51.
[13] 王俊杰,冉维强,袁惠书,等.放射性125I粒子植入治疗头颈部肿瘤.中华放射医学与防护杂志,2006, 26(1):23-26.
[14] 张建国,张杰,宋铁砾,等.放射性粒子组织间植入治疗口腔颌面部恶性肿瘤初探.中华口腔医学杂志,2006, 41(8):464-466.
[15] Zhang J, Zhang JG, Song TL, et al. 125I seed implant brachytherapy-assisted surgery with preservation of the facial nerve for treatment of malignant parotid gland tumors. Int J Oral Maxillofac Surg. 2008, 37(6):515-520.
[16] 张涛,张福君,焦德超,等.125I粒子组织间植入治疗头颈部复发和转移恶性肿瘤.中国微创外科杂志,2008, 8(5):445-447.
[17] Shields JA, Shields CL, Freire JE, et al. Plaque radiotherapy for selected orbital malignancies:preliminary observations:the 2002 Montgomery Lecturs, part 2. Ophthal Plast Reconstr Surg, 2003, 19(2):91-95.
[18] Storey MR, Landgren RC, Cottons JL,et al. Transperineal 125 iodine implantation for treatment of clinically localized prostate cancer:5-year tumor control and morbidity. Int J Radait Oncol Biol Phys, 1999, 43(3):565-570.

相似文献/References:

[1]李景涛,邓垒,张文珏,等.广泛期小细胞肺癌胸部IMRT后发生放射性肺炎的危险因素分析[J].国际放射医学核医学杂志,2016,40(2):100.[doi:10.3760/cma.j.issn.1673-4114.2016.02.003]
　Li Jingtao,Deng Lei,Zhang Wenjue,et al.Risk factor analysis for predicting radiation pneumonitis in extensive stage small cell lung cancer patients receiving IMRT thoracic radiotherapy[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(1):100.[doi:10.3760/cma.j.issn.1673-4114.2016.02.003]
[2]张毓艺,姚稚明.18F-FDG PET/CT对非小细胞肺癌淋巴结分期诊断价值的研究进展[J].国际放射医学核医学杂志,2016,40(6):447.[doi:10.3760/cma.j.issn.1673-4114.2016.06.009]
　Zhang Yuyi,Yao Zhiming.The progress of 18F-FDG PET/CT in the diagnosis of N-staging of non-small cell lung cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(1):447.[doi:10.3760/cma.j.issn.1673-4114.2016.06.009]
[3]万绪明,许祖闪,侯红军.磁共振表观弥散系数变化率对肝细胞肝癌患者单次TACE术后疗效评价的应用价值[J].国际放射医学核医学杂志,2015,39(2):129.[doi:10.3760/cma.j.issn.1673-4114.2015.02.006]
　Wan Xuming,Xu Zushan,Hou Hongjun.Applieation value of the change ratio of apparent diffusion coefficient in the therapeutic evaluation of hepatocellular carcinoma treated by single transcatheter arterial chemoembolization[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(1):129.[doi:10.3760/cma.j.issn.1673-4114.2015.02.006]
[4]王振光,王洋洋.PET/CT显像在肝细胞肝癌诊断中的研究进展[J].国际放射医学核医学杂志,2015,39(2):175.[doi:10.3760/cma.j.issn.1673-4114.2015.02.016]
　Wang Zhenguang,Wang Yangyang.The development of PET/CT imaging in the diagnosis of hepatocellular carcinoma[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(1):175.[doi:10.3760/cma.j.issn.1673-4114.2015.02.016]
[5]李欢欢,李素平,游金辉.小细胞肺癌伴副肿瘤综合征患者骨显像示肌肉摄取一例[J].国际放射医学核医学杂志,2014,38(2):140.[doi:10.3760/cma.j.issn.1673-4114.2014.02.016]
[6]戈畅,梁硕.化疗联合DC-CIK生物治疗非小细胞肺癌的临床价值及CT灌注成像的疗效评价[J].国际放射医学核医学杂志,2014,38(6):377.[doi:10.3760/cma.j.issn.1673-4114.2014.06.007]
　Ge Chang,Liang Shuo.The clinical value and CT perfusion evaluation in chemotherapy combined with DC-CIK biological treatment of non-small cell lung cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2014,38(1):377.[doi:10.3760/cma.j.issn.1673-4114.2014.06.007]
[7]黄少祥,樊体强.塞来昔布对非小细胞肺癌移植瘤的辐射增敏实验研究[J].国际放射医学核医学杂志,2013,37(3):150.[doi:10.3760/cma.j.issn.1673-4114.2013.03.006]
　HUANG Shao-xiang,FAN Ti-qiang.Radiosensitization on non-small cell lung cancer induced by celecoxib[J].International Journal of Radiation Medicine and Nuclear Medicine,2013,37(1):150.[doi:10.3760/cma.j.issn.1673-4114.2013.03.006]
[8]龙再颖,汤春静,于立明,等.甲状腺乳头状癌术后刺激状态Tg与颈部淋巴结转移关系的研究[J].国际放射医学核医学杂志,2013,37(1):27.[doi:10.3760/cma.j.issn.1673-4114.2013.01.008]
　LONG Zai-ying,TANG Chun-jing,YU Li-ming,et al.The correlation between the stimulated thyroglobulin level after surgery in papillary thyroid carcinoma and cervical lymph node metastasis[J].International Journal of Radiation Medicine and Nuclear Medicine,2013,37(1):27.[doi:10.3760/cma.j.issn.1673-4114.2013.01.008]
[9]张一秋,石洪成.肝细胞癌肿瘤新生血管影像学评价的研究进展[J].国际放射医学核医学杂志,2013,37(1):60.[doi:10.3760/cma.j.issn.1673-4114.2013.01.015]
　ZHANG Yi-qiu,SHI Hong-cheng.Advances in assessment of imaging examination for tumor neoangiogenesis induced by hepatocellular carcinoma[J].International Journal of Radiation Medicine and Nuclear Medicine,2013,37(1):60.[doi:10.3760/cma.j.issn.1673-4114.2013.01.015]
[10]于丽娟,李迎辞,王文志,等.PET-CT及PET-CT结合Lung VCAR软件对非小细胞肺癌肺门区淋巴结的诊断分析[J].国际放射医学核医学杂志,2012,36(6):323.[doi:10.3760/cma.j.issn.1673-4114.2012.06.002]
　YU Li-juan,LI Ying-ci,WANG Wen-zhi,et al.Value of PET-CT and PET-CT combined with Lung VCAR software in the diagnosis of hilar area lymph nodes of non-small cell lung cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2012,36(1):323.[doi:10.3760/cma.j.issn.1673-4114.2012.06.002]

备注/Memo

备注/Memo:
收稿日期:2010-11-17。
通讯作者:戴皓洁(Email:daihj@trhos.com)
更新日期/Last Update: 1900-01-01